Company · CIK 0001622229
Cogent Biosciences, Inc.
COGTSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$30.86+$0.85 (+2.83%)
COGT · Last trade
- Prev close
- $30.01
- Range (29d)
- $28.09 – $32.63
On the record
Recent filings
- 8-KCOGTCurrent report0001193125-26-380194 · 138.6 KBSEC(opens sec.gov)
- 144COGTCogent Biosciences, Inc.0001950047-26-008754 · 5.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACOGTCogent Biosciences, Inc.0001193805-26-001082 · 17.3 KBSEC(opens sec.gov)
- 8-KCOGTCurrent report0001193125-26-342695 · 155.4 KBSEC(opens sec.gov)
- 10-QCOGTQuarterly update0001193125-26-342393 · 8.5 MBSEC(opens sec.gov)
- 8-KCOGTCurrent report0001193125-26-341315 · 375.7 KBSEC(opens sec.gov)
- SCHEDULE 13GCOGTCogent Biosciences, Inc.0002100119-26-001323 · 7.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACOGTCogent Biosciences, Inc.0002012383-26-002235 · 11.3 KBSEC(opens sec.gov)
- 8-KCOGTCurrent report0001193125-26-267566 · 149.5 KBSEC(opens sec.gov)
- 10-QCOGTQuarterly update0001193125-26-205170 · 7.4 MBSEC(opens sec.gov)
Insiders
- Aldag JornDirector
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Booth BruceDirector
- CAIN CHRISTOPHER W.Director
- CAMPANA DARIO10% Owner
- Ettenberg SethChief Scientific Officer
- Fairmount Funds Management LLCDirector
- Ferrante Karen JeanDirector
Tickers
Addresses
business
180 THIRD AVENUE 4TH FLOOR
WALTHAM, MA
mailing
180 THIRD AVENUE 4TH FLOOR
WALTHAM, MA
Former names
- Unum Therapeutics Inc.2020-10-05
- Unum Therapeutics, Inc.2018-03-30
Same industry